| Name | SymBio Pharmaceuticals Limited | ||
| Address | Toranomon 30 Mori Bldg., 3-2-2 Toranomon, Minato-ku, Tokyo 105-0001, Japan Tel: (03) 5472-1125 Fax: (03) 5472-3054 |
||
| Established | March 25, 2005 | ||
| Capital | JPY14,244,349,815 (as of the end of September / 2019) | ||
| Board of Directors |
Fuminori Yoshida Kenji Murata Shigetoshi Matsumoto Bruce David Cheson Rockford Douglas Norby |
Representative Director Board Director Board Director <Outside> Board Director <Outside> Board Director <Outside> |
|
| Auditors |
Kiyoshi Watanabe Kesao Endo Eiji Ebinuma |
Full-Time Audit & Supervisory Board Member<Outside> Audit & Supervisory Board Member<Outside> Audit & Supervisory Board Member<Outside> |
|
| Corporate Officers |
Fuminori Yoshida Shigeo Kimura Kenji Murata Nobuo Ishida |
Corporate Officer, President and Chief Executive Officer Corporate Officer, Managing Executive Officer and Chief Commercial Officer Corporate Officer, Chief Financial Officer Corporate Officer, Chief Development Officer |
|
| Subsidiary | SymBio Pharma USA, Inc. Menlo Park, California, USA |
||
